Study Summary:
This is a 12-week, double-blind, randomized placebo-controlled study of Mesafem 7.5mg capsules in subjects experiencing moderate to severe postmenopausal hot flashes.
Qualified Participants Must:
• Be a female 40 years of age and older
•
Report moderate to severe Hot Flashes per day
•
Meet one of the following:
•
No cycle for 12 consecutive months
•
No cycle for 6 months or more with labs confirming menopausal
•
Bilateral Salpingo-ooporectomy 6 weeks or greater with or without hysterectomy
Qualified Participants May Receive:
Free study related medical care, free study related labs, free study related medication and reimbursement for time and travel may be available.